Newly curated references since 2023-05-20 |
---|
Reference | Species | Genes Addressed |
---|
Araujo D, et al. (2023) Combined Application of Antisense Oligomers to Control Transcription Factors of Candida albicans Biofilm Formation. Mycopathologia
| C. albicans | |BRG1 |EFG1 |ROB1 |
Ben Abid F, et al. (2023) Molecular characterization of Candida auris outbreak isolates in Qatar from COVID-19 patients reveals the emergence of isolates resistant to three classes of antifungal drugs. Clin Microbiol Infect
| C. auris | |CDR1 |CDR2 |CIS2 |ERG11 |ERG3 |ERG4 |ERG5 |FKS1 |SNQ2 |STE6 |TAC1b |
Beredaki MI, et al. (2023) Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints. J Antimicrob Chemother
| C. albicans | |GSC1 |GSL1 |
Brandt P, et al. (2023) High-Throughput Profiling of Candida auris Isolates Reveals Clade-Specific Metabolic Differences. Microbiol Spectr :e0049823
| C. auris | |B9J08_002974 |B9J08_003830 |B9J08_004062 |B9J08_004066 |B9J08_004188 |B9J08_004204 |B9J08_004243 |B9J08_004448 |B9J08_004538 |B9J08_004560 |B9J08_004893 |B9J08_005124 |B9J08_005570 |B9J08_005571 |MORE |
| C. albicans | |JEN1 |JEN2 |TNA1 |
Gutierrez-Escobedo G, et al. (2023) Characterization of the Trr/Trx system in the fungal pathogen Candida glabrata. Fungal Genet Biol 166:103799
| C. glabrata | |AP1 |CTA1 |GSH2 |SKN7 |TRR1 |TRR2 |TRX2 |TRX3 |
Jahanshiri Z, et al. (2023) Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC. Iran J Microbiol 15(1):163-173
| C. albicans | |CDR1 |ERG11 |MDR1 |
Jin X, et al. (2023) Erg6 Acts as a Downstream Effector of the Transcription Factor Flo8 To Regulate Biofilm Formation in Candida albicans. Microbiol Spectr :e0039323
| C. albicans | |ERG6 |FLO8 |
Karajacob AS, et al. (2023) Candida species and oral mycobiota of patients clinically diagnosed with oral thrush. PLoS One 18(4):e0284043
| C. albicans | |ITS1 |ITS2 |
Kumari P, et al. (2023) RAD51-WSS1-dependent genetic pathways are essential for DNA-Protein crosslink repair and pathogenesis in Candida albicans. J Biol Chem :104728
| C. albicans | |RAD1 |RAD2 |RAD51 |TOP1 |WSS1 |
Luther CH, et al. (2023) Integrated analysis of SR-like protein kinases Sky1 and Sky2 links signaling networks with transcriptional regulation in Candida albicans. Front Cell Infect Microbiol 13:1108235
| C. albicans | |ACE2 |C2_04360W_A |EFG1 |EFH1 |FLO8 |KIC1 |MOB1 |SKY1 |SKY2 |WOR1 |
Nouri N, et al. (2023) Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units-An In Vitro Study. Metabolites 13(4)
| C. glabrata | |EPA6 |EPA7 |
Okabayashi K, et al. (2023) Changes in the mRNA expression of glycolysis-related enzymes of Candida albicans during inhibition of intramitochondrial catabolism under anaerobic condition. PLoS One 18(4):e0284353
| C. albicans | |PFK1 |
Sudarsan S, et al. (2023) DNA compaction enhances the sensitivity of fluorescence-based nucleic acid assays: a game changer in point of care sensors? Analyst
| C. albicans | |ITS2 |
Tu J, et al. (2023) Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections. Emerg Microbes Infect :2208687
|
Wu Y, et al. (2023) Miltefosine exhibits fungicidal activity through oxidative stress generation and Aif1 activation in Candida albicans. Int J Antimicrob Agents :106819
| C. albicans | |C2_08100W_A |HOG1 |PEX8 |
Yang S, et al. (2023) Small molecule II-6s synergizes with fluconazole against Candida albicans. Int J Antimicrob Agents :106820
| C. albicans | |CDR1 |HOG1 |SFP1 |
Yau KPS, et al. (2023) The proteasome regulator Rpn4 controls antifungal drug tolerance by coupling protein homeostasis with metabolic responses to drug stress. PLoS Pathog 19(4):e1011338
| C. albicans | |RPN4 |